학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 26건 | 목록 1~10
Academic Journal
Anderson GSF; MRC Toxicology Unit and.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Ballester-Beltran J; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Giotopoulos G; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.; Guerrero JA; MRC Toxicology Unit and.; Surget S; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Williamson JC; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; So T; MRC Toxicology Unit and.; Bloxham D; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Aubareda A; MRC Toxicology Unit and.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Asby R; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.; Walker I; MRC Toxicology Unit and.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Jenkinson L; CRUK-AstraZeneca Antibody Alliance Laboratory, Cambridge, United Kingdom.; Soilleux EJ; Department of Pathology, University of Cambridge, Cambridge, United Kingdom.; Roy JP; MRC Toxicology Unit and.; Teodósio A; MRC Toxicology Unit and.; Ficken C; MRC Toxicology Unit and.; Officer-Jones L; MRC Toxicology Unit and.; Nasser S; Translational Genomics Research Institute, Phoenix, AZ.; Skerget S; Translational Genomics Research Institute, Phoenix, AZ.; Keats JJ; Translational Genomics Research Institute, Phoenix, AZ.; Greaves P; Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.; Tai YT; Dana Farber Cancer Institute, Boston, MA; and.; Anderson KC; Dana Farber Cancer Institute, Boston, MA; and.; MacFarlane M; MRC Toxicology Unit and.; Thaventhiran JE; MRC Toxicology Unit and.; Huntly BJP; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.; Lehner PJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.; Chapman MA; MRC Toxicology Unit and.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Chan DTY; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Jenkinson L; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Haynes SW; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Austin M; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Antibody Discovery & Protein Engineering, BioPharmaceuticals Research & Development, AstraZeneca, CB21 6GH Cambridge, United Kingdom.; Diamandakis A; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Burschowsky D; Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7HB Leicester, United Kingdom.; Department of Molecular and Cell Biology, University of Leicester, LE1 7HB Leicester, United Kingdom.; Seewooruthun C; Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7HB Leicester, United Kingdom.; Department of Molecular and Cell Biology, University of Leicester, LE1 7HB Leicester, United Kingdom.; Addyman A; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Fiedler S; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Ryman S; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Whitehouse J; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Slater LH; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Gowans E; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Shibata Y; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Barnard M; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Wilkinson RW; Early Oncology Discovery, Oncology Research & Development, AstraZeneca, CB21 6GH Cambridge, United Kingdom.; Vaughan TJ; Antibody Discovery & Protein Engineering, BioPharmaceuticals Research & Development, AstraZeneca, CB21 6GH Cambridge, United Kingdom.; Holt SV; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.; Cerundolo V; Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom.; Carr MD; Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7HB Leicester, United Kingdom; mdc12@leicester.ac.uk maria.groves@astrazeneca.com.; Department of Molecular and Cell Biology, University of Leicester, LE1 7HB Leicester, United Kingdom.; Groves MAT; Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom; mdc12@leicester.ac.uk maria.groves@astrazeneca.com.; Antibody Discovery & Protein Engineering, BioPharmaceuticals Research & Development, AstraZeneca, CB21 6GH Cambridge, United Kingdom.
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Academic Journal
Austin M; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Antibody Discovery & Protein Engineering, BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK.; Burschowsky D; Leicester Institute of Structural and Chemical Biology and the Department of Molecular and Cell Biology, University of Leicester , Leicester, UK.; Chan DTY; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Jenkinson L; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Haynes S; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Diamandakis A; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Seewooruthun C; Leicester Institute of Structural and Chemical Biology and the Department of Molecular and Cell Biology, University of Leicester , Leicester, UK.; Addyman A; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Fiedler S; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Ryman S; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Whitehouse J; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Slater LH; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Hadjinicolaou AV; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford , Oxford, UK.; Gileadi U; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford , Oxford, UK.; Gowans E; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Shibata Y; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Barnard M; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Kaserer T; Cancer Research UK, Cancer Therapeutics Unit, The Institute of Cancer Research , London, UK.; Sharma P; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Luheshi NM; Early Oncology Discovery, Oncology R&D, AstraZeneca , Cambridge, UK.; Wilkinson RW; Early Oncology Discovery, Oncology R&D, AstraZeneca , Cambridge, UK.; Vaughan TJ; Antibody Discovery & Protein Engineering, BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK.; Holt SV; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Cerundolo V; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford , Oxford, UK.; Carr MD; Leicester Institute of Structural and Chemical Biology and the Department of Molecular and Cell Biology, University of Leicester , Leicester, UK.; Groves MAT; Cancer Research UK AstraZeneca Antibody Alliance Laboratory , Cambridge, UK.; Antibody Discovery & Protein Engineering, BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE
Academic Journal
Lopez J; Department of Food Science , University of Tennessee , Knoxville , Tennessee 37996 , United States.; Kerley T; Department of Food Science , University of Tennessee , Knoxville , Tennessee 37996 , United States.; Jenkinson L; Department of Food Science , University of Tennessee , Knoxville , Tennessee 37996 , United States.; Luckett CR; Department of Food Science , University of Tennessee , Knoxville , Tennessee 37996 , United States.; Munafo JP Jr; Department of Food Science , University of Tennessee , Knoxville , Tennessee 37996 , United States.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 0374755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5118 (Electronic) Linking ISSN: 00218561 NLM ISO Abbreviation: J Agric Food Chem Subsets: MEDLINE
Academic Journal
Schindler C; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.; Collinson A; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.; Matthews C; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.; Pointon A; Mechanistic Safety and ADME Sciences, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.; Jenkinson L; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.; Minter RR; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.; Vaughan TJ; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.; Tigue NJ; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Chodorge M; Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK. ChodorgeM@medimmune.com.; Celeste AJ; Biosuperiors, MedImmune, Gaithersburg, USA.; Grimsby J; Cardiovascular, Renal and Metabolic diseases, MedImmune, Gaithersburg, USA. GrimsbyJ@medimmune.com.; Konkar A; Cardiovascular, Renal and Metabolic diseases, MedImmune, Gaithersburg, USA.; Davidsson P; Cardiovascular and Metabolic diseases, Innovative Medicines and Early Development Biotech unit, Translational Science, AstraZeneca R&D, Gothenburg, Sweden.; Fairman D; Clinical Pharmacology and DMPK, MedImmune, Cambridge, UK.; Jenkinson L; Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK.; Naylor J; Cardiovascular, Renal and Metabolic diseases, MedImmune, Cambridge, UK.; White N; Clinical Pharmacology and DMPK, MedImmune, Cambridge, UK.; Seaman JC; Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK.; Dickson K; Biopharmaceutical Development, MedImmune, Cambridge, UK.; Kemp B; Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK.; Spooner J; Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK.; Rossy E; Biopharmaceutical Development, MedImmune, Cambridge, UK.; Hornigold DC; Cardiovascular, Renal and Metabolic diseases, MedImmune, Cambridge, UK.; Trevaskis JL; Cardiovascular, Renal and Metabolic diseases, MedImmune, Gaithersburg, USA.; Bond NJ; Biopharmaceutical Development, MedImmune, Cambridge, UK.; London TB; Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK.; Buchanan A; Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK.; Vaughan T; Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK.; Rondinone CM; Cardiovascular, Renal and Metabolic diseases, MedImmune, Gaithersburg, USA.; Osbourn JK; Biosuperiors, MedImmune, Cambridge, UK.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Academic Journal
Longatti A; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, CB21 6GH, UK. tiguen@medimmune.com.; Schindler C; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, CB21 6GH, UK. tiguen@medimmune.com.; Collinson A; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, CB21 6GH, UK. tiguen@medimmune.com.; Jenkinson L; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, CB21 6GH, UK. tiguen@medimmune.com.; Matthews C; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, CB21 6GH, UK. tiguen@medimmune.com.; Fitzpatrick L; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, CB21 6GH, UK. tiguen@medimmune.com.; Blundy M; Core Tissue Culture, MedImmune Ltd., Granta Park, Cambridge, CB21 6GH, UK.; Minter R; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, CB21 6GH, UK. tiguen@medimmune.com.; Vaughan T; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, CB21 6GH, UK. tiguen@medimmune.com.; Shaw M; National Physical Laboratory, Teddington, TW11 0LW, UK and Department of Computer Science, University College London, London, WC1 6BT, UK.; Tigue N; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, CB21 6GH, UK. tiguen@medimmune.com.
Publisher: RSC Pub Country of Publication: England NLM ID: 101525249 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2040-3372 (Electronic) Linking ISSN: 20403364 NLM ISO Abbreviation: Nanoscale Subsets: MEDLINE
Academic Journal
Doran M; a North Wales Cochlear Implant Centre , Glan Clwyd Hospital , Bodelwyddan , Denbighshire LL18 5UJ , UK.; Jenkinson L; a North Wales Cochlear Implant Centre , Glan Clwyd Hospital , Bodelwyddan , Denbighshire LL18 5UJ , UK.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101121166 Publication Model: Print Cited Medium: Internet ISSN: 1754-7628 (Electronic) Linking ISSN: 14670100 NLM ISO Abbreviation: Cochlear Implants Int Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Jenkinson L
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어